Sara Tabtabai
she/her/hers
Assistant ProfessorCards
About
Research
Publications
2024
Cardiovascular Care in the United States: Penny Wise and Pound Foolish.
Ahmad T, Desai NR, Tabtabai S. Cardiovascular Care in the United States: Penny Wise and Pound Foolish. J Am Coll Cardiol 2024, 84: 694-695. PMID: 39142722, DOI: 10.1016/j.jacc.2024.07.001.Commentaries, Editorials and LettersWHEN ALTERNATIVE HEALTH CLINICS GO WRONG; STRONG MUSCLES, WEAK HEART AND A CASE OF ANABOLIC STEROID ASSOCIATED CARDIOMYOPATHY
Gooding K, Pillai A, Tabtabai S. WHEN ALTERNATIVE HEALTH CLINICS GO WRONG; STRONG MUSCLES, WEAK HEART AND A CASE OF ANABOLIC STEROID ASSOCIATED CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2024, 83: 3240. DOI: 10.1016/s0735-1097(24)05230-6.Peer-Reviewed Original Research
2023
Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities
Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.Peer-Reviewed Original ResearchPredictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis
Kim M, Tabtabai S, Aseltine R. Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis. The American Journal Of Cardiology 2023, 207: 407-417. PMID: 37782972, DOI: 10.1016/j.amjcard.2023.08.111.Peer-Reviewed Original ResearchConceptsElixhauser co-morbidity indexHeart failureMultivariate logistic regressionCo-morbiditiesSecondary diagnosisPatients admitted with HFPatient co-morbiditiesAdmitted with HFDetrimental to patientsPopulation of patientsLogistic regressionCo-morbidity indexReadmission riskDiagnosis of HFSecondary diagnosis of HFNationwide Readmissions DatabaseCo-morbid complicationsRenal failureComparing patientsShort-term rehospitalizationHF patientsStatistically significant predictorsPredicting 30-day readmissionIncreased riskElixhauser co-morbiditiesReadmission Patterns In Patients Admitted With Primary Or Secondary Diagnosis Of Heart Failure
Kim M, Aseltine R, Tabtabai S. Readmission Patterns In Patients Admitted With Primary Or Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 682. DOI: 10.1016/j.cardfail.2022.10.337.Peer-Reviewed Original ResearchSecondary diagnosis of HFDiagnosis of HFSecondary diagnosisPrimary diagnosisRisk of hospital admissionSecondary diagnosis of heart failureReadmission ratesIndex admissionLower household incomePrimary diagnosis of HFComorbid conditionsPercentage of readmissionsEffects of comorbid conditionsHeart failureBackground Heart failurePublic health issueSystolic HFDiastolic HFNational Readmission DatabaseRisk of mortalityReduce HF readmissionsHospital characteristicsDiagnosis of heart failureCost of hospitalizationRisk comorbiditiesThe Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population
Adeel M, Wakefield D, Soucier R, ZuWallack R, Tabtabai S. The Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population. Journal Of Cardiac Failure 2023, 29: 643. DOI: 10.1016/j.cardfail.2022.10.237.Peer-Reviewed Original ResearchChronic obstructive pulmonary diseaseHFpEF patientsHFrEF patientsHeart failurePrognostic impact of chronic obstructive pulmonary diseaseMedian LOSDiagnosis groupsHF typePresence of chronic obstructive pulmonary diseaseClinical diagnosis of chronic obstructive pulmonary diseaseConcurrent chronic obstructive pulmonary diseaseKaplan-Meier survival curvesComorbid chronic obstructive pulmonary diseaseDiagnosis of chronic obstructive pulmonary diseaseHeart failure patient populationCalcium channel blockersCox regression analysisClinical chronic obstructive pulmonary diseaseIn-hospital mortalityChronic obstructive pulmonary disease diagnosisDiagnosis of HFYears of ageImpact of chronic obstructive pulmonary diseaseObstructive pulmonary diseasePrognostic impactPredicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure
Kim M, Aseltine R, Tabtabai S. Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 681. DOI: 10.1016/j.cardfail.2022.10.335.Peer-Reviewed Original ResearchDiagnosis of HFNational Readmission DatabaseRenal failureRisk scoreCohort of HF patientsHigh riskMultivariate logistic regression analysisReadmission ratesAssociated with younger ageHigher risk of mortalityAdmitted with HFCompared patient demographicsChronic pulmonary diseasePopulation of patientsMultivariate logistic regressionThirty-day readmission ratesLogistic regression analysisElixhauser comorbiditiesRisk of mortalityReadmission riskEvidence-based clinical decision supportHigher risk of readmissionDeficiency anemiaPatient demographicsRisk of readmissionEffect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.Peer-Reviewed Original ResearchConceptsCause mortalityHeart failureTorsemide groupFurosemide groupTotal hospitalizationsCause hospitalizationEffects of torsemideDiuretic strategyPrespecified subgroupsSecondary outcomesEjection fractionMedian agePrimary outcomeHospitalizationMAIN OUTCOMEPatientsFurosemideMortalityMonthsTorsemidePrimary hypothesisSignificant differencesFinal dateOutcomesTrials
2022
The Effect of COPD Co-Morbidity on Mortality in CHF
Amann D, Akdogan R, Kaur A, ZuWallack R, Wakefield D, Tabtabai S. The Effect of COPD Co-Morbidity on Mortality in CHF. 2022, a4021-a4021. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4021.Peer-Reviewed Original ResearchEarly Palliative Care Consultation Reduces Length Of Stay And Cost In Patients Hospitalized With Acute Decompensated Heart Failure
Esstman B, Cyr P, Wakefield D, Soucier R, Tabtabai S. Early Palliative Care Consultation Reduces Length Of Stay And Cost In Patients Hospitalized With Acute Decompensated Heart Failure. Journal Of Cardiac Failure 2022, 28: s39-s40. DOI: 10.1016/j.cardfail.2022.03.106.Peer-Reviewed Original ResearchPalliative care consultationLength of stayEarly palliative care involvementAssociated with increased health care costsNon-cancer diagnosesPalliative care involvementReduce length of staySt Francis HospitalAcute decompensated heart failureHealth care costsReduced quality of lifeQuality of lifePredictors of length of stayAssociated with reduced lengthCare consultationPalliative careHigher severity of illnessCare involvementProlonged length of stayMedian length of staySeverity of illnessCare costsIn-hospital mortalityPractice advisoryAssociated with decreased LOS
Academic Achievements & Community Involvement
Teaching & Mentoring
Mentoring
Alexandra Schwann, MD
cardiology fellow2023 - PresentAshwin Pillai
Internal medical resident2021 - 2024Kaitlyn Gooding
Internal medical resident2021 - Present
Clinical Care
Overview
Sara Tabtabai, MD, is a cardiologist who specializes in heart failure and cardiovascular medicine. She diagnoses and treats conditions related to advanced heart failure, women's heart disease, cardio-obstetrics, and amyloid cardiomyopathy (where abnormal proteins accumulate in the heart muscle, leading to damage and impaired heart function).
As an assistant professor at Yale School of Medicine, Dr. Tabtabai is involved in research aimed at enhancing the understanding and treatment of heart failure.
Dr. Tabtabai earned her medical degree at the University of Connecticut School of Medicine. She then completed residency and fellowship training in internal and cardiovascular medicine, as well as advanced training in heart failure and transplantation, at Massachusetts General Hospital.
Clinical Specialties
Cardiovascular Medicine; Heart Failure
Fact Sheets
Cardiac Amyloidosis
Learn More on Yale MedicineAmyloidosis
Learn More on Yale MedicineHeart Disease in Women
Learn More on Yale MedicineHeart Transplant
Learn More on Yale Medicine
Yale Medicine News
News
News
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.